✦ LIBER ✦

Outcome of Patients Who Refuse Cystectomy after Receiving Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

✍ Scribed by Harry W. Herr

Book ID: 113610493
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 371 KB
Volume: 54
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2007.12.031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficient delivery of radical cystectomy

Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer : A multidisciplinary approach

✍ Ajjai S. Alva; Christopher T. Tallman; Chang He; Maha H. Hussain; Khaled Hafez; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

Pathology-based risk stratification of m

Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches

✍ Fumitaka Koga; Yasuhisa Fujii; Hitoshi Masuda; Noboru Numao; Minato Yokoyama; Ju 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB

Morbidity and Quality of Life in Elderly

Morbidity and Quality of Life in Elderly Patients Receiving Ileal Conduit or Orthotopic Neobladder After Radical Cystectomy for Invasive Bladder Cancer

✍ Filippo Sogni; Maurizio Brausi; Bruno Frea; Carlo Martinengo; Fabrizio Faggiano; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Treatment options for muscle-invasive ur

Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin : Report of Southwest Oncology Group Trial 8733

✍ Celestia S. Higano; Catherine M. Tangen; Wael A. Sakr; James Faulkner; Saul E. R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

## Abstract ## BACKGROUND. Many patients with invasive urothelial cell cancer are poor candidates for cisplatin‐based chemotherapy, and many are high risk for cystectomy. Southwest Oncology Group Trial 8733 was designed to address treatment for such patients. ## METHODS. Eligible patients had pr

Should All Patients with Non–Muscle-Inva

Should All Patients with Non–Muscle-Invasive Bladder Cancer Receive Early Intravesical Chemotherapy after Transurethral Resection? The Results of a Prospective Randomised Multicentre Study

✍ Sigurdur Gudjónsson; Lars Adell; Fekadu Merdasa; Ronnie Olsson; Bruno Larsson; T 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 596 KB

MP-13.07: Downstaging and pathoanatomica

MP-13.07: Downstaging and pathoanatomical outcome following neoadjuvant cisplatinum based combination chemotherapy for muscle invasive bladder carcinoma: An analysis of selected patients from two combined randomised prospective Nordic trials

✍ A. Sherif; E. Rintala; O. Mestad; J. Nilsson; L. Holmberg; S. Nilsson; P. Malmst 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 65 KB